drugset / Trial / NCT01266694

Cochicine Treatment for Post- Operative Pericardial Effusion

NCT01266694 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Background: The incidence of asymptomatic pericardial effusion is high after cardiac surgery. Objective: To assess whether colchicine is effective in reducing post operative pericardial effusion volume. Design: Multicenter, randomized, double-blind, placebo-controlled study. Intervention : colchicine 1mg vs placebo, once daily for 14 days Setting :10 post operative cardiac rehabilitation centers. Patients: 200 patients at high risk of tamponade because of moderate to large persistent pericardial effusion (grade 2, 3 or 4 on a scale of 0 to 4 measured by echocardiography) more than 7 days after cardiac surgery. Measurements: The main end point will be change in effusion grade after 14 days of treatment. Secondary endpoints include frequency of late cardiac tamponade.

Timeline

Start
2011-04
Primary completion
2013-03
Completion
2014-01

Outcome

Missed primary endpoint

paper The mean difference in grade decrease between groups was -0.19 (95% CI -0.55 to 0.16, p=0.23). PMID 26076938 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 1 mg Oral

Indications